, the exact
molecular mechanisms and signaling pathways that explain why claudin proteins are so important
be used for diagnosis and prognosis, including the response of a particular patient to
therapyKHABIBOV, M.,
GARIFULLIN, A.,
KHAMITOV, F.,
KHALIKOVA, L.,
BOUMBER, Y.,
KHADDOUR, K.,
FERNANDEZ, M.,
KUZNETSOVA, N.,
KIT, O.,
KHARIN, L. (2022) in the pathogenesis of GBM, as well as
therapies that
target these pathways. Glioblastoma remains a diffi‑
cult
. Glioblastoma (GBM), a grade IV brain tumor, is known for its heterogeneity and resistance to
therapy. Modern
, it is necessary to develop an effective
therapy for NF1. The effectiveness of complex
therapy of NF1 with use
Tyurin, Anton V.,
Akhiyarova, Karina E.,
Valishin, Damir A.,
Sadretdinova, Lidiya D.,
Khusainova, Leonora N.,
Zagidullin, Naufal S.,
Gantseva, Khalida K.,
Pavlov, Valentin N. (2022) The objective of our study was the analysis of using immunosuppressive
therapy in patients